Back
Speaker illustration

Doctor Weike Bao

AstraZeneca, Gaithersburg (United States of America)

Presentations

Treatment with activin type ii receptor antibody improves cardiac function in mice after myocardial infarction

Event: ESC Congress 2022

Topic: Pharmacotherapy

Session: Chronic heart failure - Bench studies

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources